Insights Into Acute Lymphoblastic Leukemia (ALL)
Perspectives on current treatment practices regarding adult and AYA ALL, the role of MRD, and current treatment practices regarding relapsed disease
![Elias Jabbour MD Anderson Cancer Center Aptitude Health](https://www.aptitudehealth.com/wp-content/uploads/2019/12/Elias-Jabbour-MD-Anderson-Cancer-Center-Aptitude-Health.jpg)
Meeting Chair
Elias Jabbour, MD
The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Look Inside This Report
Download a sample of this report and start discovering the insights
Report Snapshot
Insights on the following therapies were obtained
- pegaspargase
- asparaginase
- imatinib
- dasatinib
- ponatinib
- blinatumomab
- inotuzumab ozogamicin
- chimeric antigen receptor (CAR) T-cell therapy
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- A moderated roundtable discussion focusing on treatment of ALL was held on October 26, 2019, in Seattle, WA
- Disease state and data presentations were developed in conjunction with a medical expert from MD Anderson Cancer Center
- The group of advisors comprised 8 community oncologists from the Northwest (USA)
- Data collection was accomplished through use of audience response system questioning and in-depth moderated discussion